This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Azria, E. Articles by Castaigne, D. Search for Related Content PubMed PubMed Citation Articles by Azria, E. Articles by Castaigne, D.

Results of Hysterectomy in Patients With Bulky Residual Disease at the End of Chemoradiotherapy for Stage IB2/II Cervical Carcinoma

¹ Department of Surgery, Institut Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif, France
² Department of Radiation Therapy, Institut Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif, France
³ Department of Medical Oncology, Institut Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif, France
⁴ Departments of Pathology, Institut Gustave Roussy, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Correspondence: Address correspondence and reprint requests to: Philippe Morice, MD; E-mail: morice{at}igr.fr.

Background: We assessed the clinical outcome after hysterectomy in patients with bulky residual disease after chemoradiotherapy for stage IB2/II cervical carcinoma.

Methods: Subjects were 10 patients who had bulky (>2 cm) residual disease in the cervix after external radiotherapy (45 Gy) combined with concomitant chemotherapy (cisplatin 40 mg/m²/week) and uterovaginal brachytherapy (15 Gy).

Results: Extrafascial hysterectomy was performed in three patients, type II radical hysterectomy was performed in six patients, and pelvic exenteration was performed in one patient. Pelvic lymphadenectomy was performed in eight patients, and para-aortic lymphadenectomy was performed in eight. Five patients had nodal involvement (pelvic nodes in four and para-aortic nodes in four), and six had lymphovascular space involvement. Surgical margins were free in nine patients. Seven patients developed grade 2 (n = 3) and/or grade 3 (n = 4) complications. The median duration of follow-up after surgery was 22 months (range, 1–37 months). With follow-up available in nine patients, seven relapsed, and only two remained disease free.

Conclusions: This series confirms the high rate of nodal spread in patients with bulky residual cervical disease after chemoradiotherapy. Furthermore, patients who underwent hysterectomy had a high complication rate. Only two patients are alive and disease free. The results of surgery are disappointing; surgery does not seem to improve the survival of these patients.

Key Words: Cervical cancer • Completion surgery • Chemoradiotherapy • Morbidity

This article has been cited by other articles:

				Y. Delpech, C. Haie-Meder, A. Rey, Y. Zafrani, C. Uzan, S. Gouy, P. Pautier, C. Lhomme, P. Duvillard, D. Castaigne, et al. Para-Aortic Involvement and Interest of Para-Aortic Lymphadenectomy after Chemoradiation Therapy in Patients with Stage IB2 and II Cervical Carcinoma Radiologically Confined to the Pelvic Cavity Ann. Surg. Oncol., November 1, 2007; 14(11): 3223 - 3231. [Abstract] [Full Text] [PDF]